G - Physics – 01 – N
Patent
G - Physics
01
N
G01N 33/68 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2574424
The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of IPF-1 in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.
L'invention concerne la régulation de la progression d'une maladie et le diagnostic de la défaillance des cellules bêta chez des diabètes par mesure des niveaux d'IPF-1 dans un échantillon liquide, et par criblage de nouveaux composés pour la prévention et/ou le traitement du diabète.
Christ Andreas
Evers Stefan
Krapfenbauer Kurt
Sebokova Elena
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Insulin promoter factor 1 as target/marker of beta cell failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin promoter factor 1 as target/marker of beta cell failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin promoter factor 1 as target/marker of beta cell failure will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1399756